Journals / Journal of Health Sciences and Medicine / 2021 / Cilt: 4 - Sayı: 2

The effect of phosphorolcoline-coated cardiopulmonary by-pass circuits on morbidity and mortality in patients with congenital open cardiac surgery

Pages
160–165
Publication Date
2021-03-28
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that the increase in d-dimer values with fibrinogen was less in Group P.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim in this study is to investigate the relationship between mortality and morbidity of phosphorylcholine coated oxygenator circuit used in heart-lung machine in congenital open heart surgery operations.
📊
Key Findings & Data:Sami Ulus Child Diseases Training and Research Hospital Cardiovascular Surgery Clinic between 2008-2009. 30 congenital heart patients were included.
💡
Conclusion & Impact:It was found that the increase in d-dimer values with fibrinogen was less in Group P.
🔬Design:Research Article
📍Scope:2008-2009 Verileri
⚙️Variables:Phosphorylcholine coated oxygenator · congenital heart surgery · cardiopulmonary bypass

Abstract

Objective: Our aim in this study is to investigate the relationship between mortality and morbidity of phosphorylcholine coated oxygenator circuit used in heart-lung machine in congenital open heart surgery operations. Materials and Methods: The study was conducted in Dr. Sami Ulus Child Diseases Training and Research Hospital Cardiovascular Surgery Clinic between 2008-2009. 30 congenital heart patients were included. The patients were divided into 2 groups of 15 people. In one of the groups, a phosphorylcholine coated oxygenator circuit was used in the heart lung machine (Group P). In the other group, a standard oxygenator circuit was used (Group C).Congenital heart surgery was performed for 19 Ventricular Septal Defects (VSD), 5 Secundum Atrial Septal Defects (ASD), 3 Primum ASD, 2 Mitral insufficiency and 1 Discret subaortic membrane. Extubation times, intensive care and discharge times, 24-hour drainage follow-up, inotropic drug use, blood and fresh frozen plasma (FFP) transfusion amount, aspartate aminotransferase, alanine aminotransferase, creatine phosphokinase-MB, urea, blood urea nitrogen, creatinine, white cell number of platelets, lactate dehydrogenase, albumin, total protein, C-reactive protein, prothrombin time, partial thromboplastin time, fibrinogen, D-dimer, C5a and elastase levels were compared perioperatively. Results: In the study, it was determined that the discharge time was shorter in Group P. It was found that the increase in d-dimer values with fibrinogen was less in Group P. These were found to be statistically significant (p 0.05). There was no mortality in either group. Conclusion: In this study, phosphorylcholine-coated oxygenator did not significantly reduce the inflammatory response during cardiopulmonary by-pass (CPB). There was no difference between the two groups in terms of morbitidity and mortality.However, the fact that fibrinogen values, which are the acute phase reactants, are lower than the control group and the increase in d-dimer values remain limited may be important in terms of hemocompatibility of the phosphorylcholine coated circuit.

🔖

Cite This Article

BOLAT, A., SURER, S., GÜLBAHAR, Ö., BOLAT, E., GÜLTEKİN, Y., KUTSAL, A. (2021). The effect of phosphorolcoline-coated cardiopulmonary by-pass circuits on morbidity and mortality in patients with congenital open cardiac surgery. Journal of Health Sciences and Medicine, Cilt: 4 - Sayı: 2, 160–165. https://ajindex.com/articles/776978

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Zahler S, Massoudy P, Hartl H, Hähnel C, Meisner H, Beckeret BF. Acute cardiac inflammatory responses to post ischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999; 41: 722-30.
  2. Gemalmaz H, Gültekin Y, Hasanov Y. Yurtdışında yeni kurulan kalp merkezindeki sonuçlar. AJHM 2020; 3: 11-7.
  3. Siregar S, Groenwold RHH, De Mol BAJM, et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow up? Eur J Cardio Thoracic Surg. 2013; 44: 875-83.
  4. McGiffin DC, Kirklin Ki. Cardiopulmonary bypass forcardiacsurgery. in Sabiston DC, Spencer FC. Surgerythe Chest. 61h ed, yol II, Philadelphia: WB Saunders, 1256-71, 1995. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand. 2001;/45:/671-9.
  5. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. AnnThoracSurg 1993; 55: 552-9. Casey LC. Role of cytokines in thepathogenesis of cardiopulmonary induced multisystem organ failure. Ann Thorac Surg 1993; 56: 92-6. Walport MJ. Complement. N Engl J Med 2001; 344: 1058. Mansuroğlu D, Kirali K, Yakut C. Kardiyopulmoner bypass sırasındaki enflamatuvar yanıt: hücresel yanıt, enflamasyonun diğer mediyatörleri, akut enflamasyonun kontrolü. Türkiye Klinikleri Kalp Damar Cerrahisi Derg 2004; 5: 183-96. Ilion MK. Langlon PE. Taylor ML, et al. Differentialexpression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118: 930-7. Mair P. Mair J. Seibt I Furtwaengler W, Balogh D. Plasma elastase concentrations and pulmonary function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 184-5.
  6. Windsor AC, Mullen PG, Fowler AA, Sugerman HJ. Role of theneutrophil in adult respiratory distress syndrome. Br J Surg1993; 80: 10-7.
  7. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation; pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-44.
  8. Wan S, Le Clerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass, mechanisms involved and possible therapeutic strategies. Chest 1997; 112: 676-92. Günaydin E. Emerging Technologies in biocompatible surface modifying additives quest for physiologiccardiopulmonary bypass. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 187-96.
  9. De Somer F, François K, vanOeveren W et al. Phosphorylcholine coating of extra corporeal circuits provides natural protection against blood activat